Monthly Archives: January 2017

24 01, 2017

St. Louis Business Journal: RiverVest leads $17M investment in Adarza, brings on new president

2017-09-11T12:53:54+00:00 January 24th, 2017|

RiverVest leads $17 million investment in Adarza, brings on new president

19 01, 2017

ADARZA BIOSYSTEMS CLOSES ON $17 MILLION SERIES C FINANCING

2018-05-02T01:29:44+00:00 January 19th, 2017|

ROCHESTER, NY and ST LOUIS, MO (Jan. 19, 2017) – Adarza BioSystems, Inc., a leading next generation innovator in label-free, multiplex assays, announced today that it has closed a $17M Series C financing. Proceeds from the financing will be used to further expand production capacity in its St. Peters, MO manufacturing facility and fund final development and commercialization of Adarza’s first immunoassay product consumable and instrument platform. Adarza develops and manufactures immunoassay technology that can identify proteins and genetic markers in medical samples such as blood. The technology, which comes in the form of microchips, [...]

16 01, 2017

Event Update

2017-09-11T12:54:27+00:00 January 16th, 2017|

  Join us at the 15th Cytokines & Inflammation Conference, February 6-7, 2017 in San Diego, CA. Booth #6. And check our poster while you’re there: “A Multiplex Panel for Simultaneously Profiling Toxicant Levels and Biological Response Indicators in Serum Samples”.